N2OFF Completed Merger with Cancer Drug Discovery Company Targeting Tough-to-Treat Pancreatic and Lung Cancers
Acquired-byAcquisition
N2OFF Announces Closing of Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
Acquired-byAcquisition
SciSparc Announces Closing of the Sale to N2OFF of Majority-Owned Subsidiary MitoCareX, Advancing Drug Discovery for Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
Acquired-by
N2OFF Regains Compliance with Nasdaq Minimum Bid Price Requirement
Partners
SciSparc: N2OFF Shareholders Approve Merger with SciSparc’s Majority Owned Subsidiary MitoCareX, a Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
Acquired-by
N2OFF Stockholders Approve Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
AcquisitionInvestment
N2OFF Announces Reverse Stock Split
Public Trading
N2OFF Provides Business Update on Successful Execution of Solar and Energy Storage Initiatives Across Europe
PartnersInvestment
N2OFF to Expand its Melz Solar Project with Battery Storage
InvestmentPartners
N2OFF Completes $1.2 million of its $2.7 million Total Commitment to Finance 196MWp Battery Energy Storage Assets in Italy
InvestmentProduct StagePartners
N2OFF is Increasing its Investment in Melz Project to Explore Additional 40-60 MW Battery Storage
InvestmentPartners
N2OFF Energy Targets European’s Energy Crises with Fourth Regional Battery Project
InvestmentPartners
N2OFF via Solterra Expands European Footprint with Entry into Fourth Project – a Battery Storage Venture in Poland
InvestmentPartners
N2OFF Announces Potential to Maximize Investment Opportunity Following New Regulation in Germany
PartnersAcquisitionInvestment
N2OFF Full Year 2024 Earnings: US$0.89 loss per share (vs US$5.43 loss in FY 2023)
N2OFF Signs Non-Binding LOI for Potential 380MW Battery Energy Storage Projects
PartnersInvestment
N2OFF Secures Definitive Agreement to Commercialize 196 MWp Battery Storage Projects
AcquisitionPartners
N2OFF Establishes a US Subsidiary for Its Solar PV Operations
PartnersProduct Stage
N2OFF Signs Definitive Agreement to Acquire Next-Gen Computational Drug Discovery Company, Targeting Hard To Treat Cancers
AcquisitionInvestment
N2OFF and Solterra Announce the Closing of a Definitive Agreement to Develop 196 MWp Battery Storage Projects in Italy
PartnersInvestment
+ 64 more articles